The efficiency and safety of low-dose intravenous indomethacin for closure of patent ductus arteriosus in preterm neonate: a randomized controlled trial

Abstract Patent ductus arteriosus (PDA) is a common complication in prematurity. Intravenous indomethacin, three doses, is an effective medication for closure PDA, but complications about renal impairment and gastrointestinal (GI) problems should be considered. This study aimed to compare the effica...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Wasana Hongkan, Narueporn Petarwut, Thanatda Siriporn, Nirucha Thamwiriyakul, Tharathorn Durongbhandhu
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Nature Portfolio 2025-11-01
Serie:	Scientific Reports
Ämnen:	Patent ductus arteriosus Prematurity Intravenous indomethacin Closure PDA Low-dose indomethacin Complication of indomethacin
Länkar:	https://doi.org/10.1038/s41598-025-23285-4
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!